MY168634A - A vector for producing antigenic peptides of white spot syndrome baculovirus complex and uses thereof - Google Patents
A vector for producing antigenic peptides of white spot syndrome baculovirus complex and uses thereofInfo
- Publication number
- MY168634A MY168634A MYPI2010005866A MYPI2010005866A MY168634A MY 168634 A MY168634 A MY 168634A MY PI2010005866 A MYPI2010005866 A MY PI2010005866A MY PI2010005866 A MYPI2010005866 A MY PI2010005866A MY 168634 A MY168634 A MY 168634A
- Authority
- MY
- Malaysia
- Prior art keywords
- vector
- antigenic peptides
- white spot
- spot syndrome
- syndrome baculovirus
- Prior art date
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
A vector comprising deoxyribonucleic acid sequence of SEQ ID NO.1 which encodes modified antigenic peptides VP28 of White Spot Syndrome Baculovirus Complex.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI2010005866A MY168634A (en) | 2010-12-10 | 2010-12-10 | A vector for producing antigenic peptides of white spot syndrome baculovirus complex and uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI2010005866A MY168634A (en) | 2010-12-10 | 2010-12-10 | A vector for producing antigenic peptides of white spot syndrome baculovirus complex and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MY168634A true MY168634A (en) | 2018-11-14 |
Family
ID=79169839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2010005866A MY168634A (en) | 2010-12-10 | 2010-12-10 | A vector for producing antigenic peptides of white spot syndrome baculovirus complex and uses thereof |
Country Status (1)
Country | Link |
---|---|
MY (1) | MY168634A (en) |
-
2010
- 2010-12-10 MY MYPI2010005866A patent/MY168634A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ593550A (en) | ANTI-Siglec-15 ANTIBODY | |
UA111818C2 (en) | ANTIBODY AGAINST CSF-1R | |
WO2010129895A3 (en) | Cd133 epitopes | |
UA118167C2 (en) | Peptides and their use | |
MX2020010399A (en) | 3-epimerase. | |
MY159135A (en) | Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof | |
MY180714A (en) | Factor viii chimeric and hybrid polypeptides, and methods of use thereof | |
NZ596735A (en) | Recombinant production of peptides | |
WO2009114702A3 (en) | Recombinant production of authentic human proteins using human cell expression systems | |
NZ607224A (en) | Non-lipidated variants of neisseria meningitidis orf2086 antigens | |
GB0917002D0 (en) | Improved shigella blebs | |
EA201391254A1 (en) | METHOD FOR OBTAINING GUANYLATZCLAZE AGONISTS C | |
WO2012051498A3 (en) | Antibodies that bind amyloid oligomers | |
PH12015500771A1 (en) | Novel fc gamma receptor iib variants | |
MX2010010457A (en) | Recombinant rhinovirus vectors. | |
AR128395A2 (en) | NOVEL PEPTIDES ABLE TO INDUCE THE FORMATION OF ANTIBODIES AGAINST PCSK9 | |
GB201118394D0 (en) | Vaccine | |
JP2010265269A5 (en) | ||
IN2014DN09367A (en) | ||
MX2015001542A (en) | Method. | |
MX2011012623A (en) | Casb7439 constructs. | |
WO2011034659A3 (en) | Advantageous mu-opiate receptor peptide compounds | |
AR083766A1 (en) | IMMUNOGENIC PEPTIDE | |
MY168634A (en) | A vector for producing antigenic peptides of white spot syndrome baculovirus complex and uses thereof | |
EP2504029A4 (en) | Compositions, methods and uses for expression of enterobacterium-associated peptides |